Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex

Sirolimus and tuberous sclerosis-associated renal angiomyolipomas

(2010) L. Krischock et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity

(2010) Michael Haidinger et al.   TRANSPLANT INTERNATIONAL

Rapamycin as a Therapy of Choice After Renal Transplantation in a Patient With Tuberous Sclerosis Complex

(2009) A. Tarasewicz et al.   TRANSPLANTATION PROCEEDINGS

Regression of Pulmonary Lymphangioleiomyomatosis (PLAM)-associated Retroperitoneal Angiomyolipoma Post–Lung Transplantation With Rapamycin Treatment

(2008) Judith M. Morton et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Sirolimus Therapy in Tuberous Sclerosis or Sporadic Lymphangioleiomyomatosis

(2008) D. Mark Davies et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

(2008) John J. Bissler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis

(2008) Elahna Paul et al.   NEW ENGLAND JOURNAL OF MEDICINE